CMPSHIGH SIGNALFINANCIAL10-K

CMPS experienced catastrophic financial deterioration with current liabilities exploding 628% to $248M, stockholders' equity turning negative at -$53M, and net losses nearly doubling to $288M.

The company has moved from a stable financial position to technical insolvency, with negative equity indicating liabilities now exceed assets. The massive increase in current liabilities suggests either significant new debt obligations or potential acceleration of existing debt, creating immediate liquidity concerns that could threaten the company's ability to continue operations.

Comparing 2026-03-24 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

CMPS experienced severe financial distress with current liabilities skyrocketing 628% to $248M while total liabilities increased 346% to $263M, driving stockholders' equity deeply negative to -$53M from a positive $155M. Net losses nearly doubled to $288M and operating cash outflows worsened by 32% to $157M, indicating deteriorating operational performance alongside the balance sheet crisis. This financial profile suggests potential insolvency issues and raises serious going concern questions for this clinical-stage biotech company.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
+628.5%
$34.0M→$247.8M

Current liabilities surged 628.5% — significant near-term obligations; verify ability to meet short-term debt.

Total Liabilities
Balance Sheet
+346.3%
$59.0M→$263.2M

Liabilities grew 346.3% — significant increase in debt or obligations, assess impact on financial flexibility.

Stockholders Equity
Balance Sheet
-134.2%
$154.7M→-$52.8M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Net Income
P&L
-85.6%
-$155.1M→-$287.9M

Net income declined 85.6% — review whether driven by operations, interest costs, or non-recurring items.

Operating Cash Flow
Cash Flow
-31.9%
-$119.2M→-$157.2M

Operating cash flow fell 31.9% — earnings quality concerns; investigate working capital changes and non-cash items.

LANGUAGE CHANGES
NEW — 2026-03-24
PRIOR — 2025-02-27
ADDED
Dollar), the risk of an economic slowdown or recession in the U.S., instability in the banking system, overall market volatility in the U.S.
or the UK, including as a result of, among other factors, geopolitical conflict (such as, the war between Russia and Ukraine and conflict in the Middle East), international tensions or instability (including from the effects of announced or future tariff increases), significant changes in U.S.
References to we, our, us and the Company refer to Compass Pathways plc.
We expect to incur losses for the foreseeable future and may never achieve or maintain profitability; Unless and until we generate product revenue and achieve and sustain profitability, we will continue to need additional financing to fund our operations and capital expenditures.
If we are unable to do so, our commercialization prospects would be limited and our business would be harmed; In our clinical trials, we currently rely on specially trained, licensed healthcare professionals working at third-party clinical trial sites and upon regulatory approval we expect to continue to rely on healthcare professionals working at third-party sites, to monitor and safeguard participants during administration of our COMP360 psilocybin treatment.
+7 more — sign up free →
REMOVED
Dollar, the risk of economic slowdown or recession in the U.S., instability in the banking system, overall market volatility in the U.S.
or the UK, including as a result of, among other factors, the ongoing war between Russia and Ukraine, conflict in the Middle East, the potential for significant changes in U.S.
We expect to incur losses for the foreseeable future and may never achieve or maintain profitability; We will need substantial additional funding to complete the development and commercialization of our investigational COMP360 psilocybin treatment.
Our outstanding warrants may not be exercised for cash before such warrants expire and we may not receive any additional proceeds from such warrants.
Our ability to raise additional funds may be adversely impacted by macroeconomic conditions, changing regulatory conditions, and disruptions to and volatility in the credit and financial markets in the U.S.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →